Malaysia Ministry of Health Launching 500 Patient Ivermectin Trial at 10 Public Hospitals Investigating Efficacy for Critical COVID-19 Patients

Malaysia Ministry of Health Launching 500 Patient Ivermectin Trial at 10 Public Hospitals Investigating Efficacy for Critical COVID-19 Patients

In Malaysia, the Ministry of Health (MIH), as well as the Institute for Clinical Research, initiated major clinical trials investigating the use and efficacy of Ivermectin for high-risk COVID-19 patients at 12 Ministry of Health hospitals across the nation. Tan Sri Dr. Noor Hisham Abdullah, the General Director of Health, shared in recent media that the Food and Drug Administration (FDA) approved drug (for fighting several neglected tropical diseases, such as onchocerciasis and strongyloidiasis) believes the evidence is still inconclusive for the standard use against the COVID-19 indication. But the Malay research and health authorities believe the promise is high due to a portfolio of case studies and clinical trials.

COVID-19 in Malaysia

As reported by Johns Hopkins University data, Malaysia has experienced its worst surge of the COVID-19 pandemic starting in April, with reported incidents of infection rising from 1,300 cases reported on April 6 of this year to 8,290 on May 28th and as of June 4, 7,748 daily cases.

This represents the worst second wave of the pandemic, which has impacted other nations in Asia, such as India, of course, but also Thailand and others. Tria...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee